PhillipCapital is maintaining its “neutral” call on Raffles Medical with a revised target price of 94 cents. This is down 5 cents or 5.05% from its previous 99 cent call, analyst Tay Wee Kuang says in a July 29 note.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $99.9/year*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply